Relationship between EGFR and multidrug resistance protein in non-small cell lung cancer
10.3969/j.issn.1005-1678.2017.05.030
- VernacularTitle:非小细胞肺癌中EGFR及多药耐药蛋白与化疗疗效的关系
- Author:
Cheng XU
;
Huarong LUO
;
Meifu GAN
- Keywords:
non-small cell lung cancer;
immunohistochemical;
epidermal growth factor receptor;
multi-drug resistance proteins
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(5):93-95,97
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of epidermal growth factor receptor (EGFR) and multidrug resistance protein, and it's relationship with efficacy of chemotherapy in NSCLC.MethodsThe immunohistochemical (EnVision method) was used to detect the expression of EGFR and LRP, P-gp, MRP, GST-π in 95 cases of NSCLC tissues and 15 cases of normal lung samples.ResultsEGFR in NSCLC tissues was significantly correlated with the history of smoking, pathological types of cancer(squamous cell carcinoma vs adenocarcinoma), presence of lymph node metastasis, and TNM stages (P< 0.05).The positive expression rate of LRP and MRP in adenocarcinoma were higher than squamous cell Carcinoma (P< 0.05), and MRP in high differentiate cancer was higher than low differentiate cancer (P< 0.05).The expression of MRP and LRP, PGP and GST-π in NSCLC were positive correlation(r=0.341, P=0.001;r=0.213, P=0.038), there is no correlation between EGFR with LRP, P-gp, MRP, GST-π.EGFR-negative chemotherapy efficiency (62.5%) was significantly higher than EGFR-positive(37.5%, P< 0.05).ConclusionEGFR and multi drug resistance proteins are overexressed in NSCLC tissues.multi drug resistance proteins have a synergistic to drug resistance.EGFR could be used to objectively predict chemotherapy effect and prognosis of NSCLC.
